PBPIA
Pivotal bioVenture Partners Investment Advisor’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4M | Buy |
1,305,125
+594,391
| +84% | +$19.3M | 26.3% | 2 |
|
|
2025
Q1 | $26.8M | Buy |
710,734
+6,900
| +1% | +$261K | 21.72% | 3 |
|
|
2024
Q4 | $57.6M | Buy |
703,834
+64,295
| +10% | +$5.26M | 38.91% | 1 |
|
|
2024
Q3 | $73.1M | Sell |
639,539
-153,497
| -19% | -$17.5M | 43.38% | 1 |
|
|
2024
Q2 | $59.9M | Hold |
793,036
| – | – | 46.04% | 1 |
|
|
2024
Q1 | $54.2M | Hold |
793,036
| – | – | 34.82% | 1 |
|
|
2023
Q4 | $49.8M | Hold |
793,036
| – | – | 12.63% | 2 |
|
|
2023
Q3 | $40.4M | Hold |
793,036
| – | – | 16.13% | 2 |
|
|
2023
Q2 | $39.6M | Buy |
793,036
+99,997
| +14% | +$4.99M | 13.06% | 2 |
|
|
2023
Q1 | $26M | Hold |
693,039
| – | – | 10.7% | 2 |
|
|
2022
Q4 | $33.2M | Sell |
693,039
-83,000
| -11% | -$3.98M | 14.45% | 2 |
|
|
2022
Q3 | $18.6M | Sell |
776,039
-56,127
| -7% | -$1.35M | 6.81% | 3 |
|
|
2022
Q2 | $18.1M | Sell |
832,166
-279,319
| -25% | -$6.08M | 9.12% | 2 |
|
|
2022
Q1 | $26.8M | Hold |
1,111,485
| – | – | 12.7% | 2 |
|
|
2021
Q4 | $26.4M | Sell |
1,111,485
-293,936
| -21% | -$6.99M | 11.06% | 2 |
|
|
2021
Q3 | $35.7M | Hold |
1,405,421
| – | – | 12.6% | 3 |
|
|
2021
Q2 | $31.6M | Hold |
1,405,421
| – | – | 12.47% | 2 |
|
|
2021
Q1 | $27.8M | Sell |
1,405,421
-817,549
| -37% | -$16.1M | 8.91% | 4 |
|
|
2020
Q4 | $59.1M | Buy |
+2,222,970
| New | +$59.1M | 19.47% | 2 |
|